# Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting

> **NCT03336450** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 3 (actual)

## Conditions studied

- Nervous System Diseases

## Interventions

- **DRUG:** SHP615
- **DRUG:** MHOS/SHP615

## Key facts

- **NCT ID:** NCT03336450
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-23
- **Primary completion:** 2020-10-13
- **Final completion:** 2020-10-13
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2021-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03336450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03336450, "Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03336450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*